The purpose of this proposal is to request funds to continue the expansion of the research program of the Howard University Health Sciences Center. Included are research protocols from representative faculty of the Colleges of Medicine, Nursing and Pharmacy & Pharmacal Sciences. The principal investigators are distributed according to departments as follows: 1) College of Medicine- Departments of Medicine, Obstetrics & Gynecology, Pediatrics and Child Health, Surgery, and the Center for Sickle Cell Disease; 2) College of Nursing- Department of Community and Mental Health Nursing; and 3) College of Pharmacy and Pharmacal Sciences- Department of Medicinal Chemistry. The primary goal of the program is to continue existing MBRS supported programs and to initiate new research activities in departments whose faculty have not traditionally participated in Biomedical Research. Of the 13 subprojects in this proposal; five (5) were submitted by faculty currently funded by the MBRS program and eight (8) are from faculty who are not currently receiving MBRS support. The majority (10/13) of the principal investigators are physician investigators. Interdisciplinary as well as disciplinary collaboration between clinical and basic scientists therefore, continues to be the central theme of this MBRS program. A secondary goal of the program is to actively involve health professional students, on a short term basis, in biomedical research. It is anticipated that the continued interactions between clinical investigators and health professional students will serve as an incentive for such students to seriously consider academic medicine as a career. An additional expected outcome is that diligent pursuit of the research goals described in this application will result in an increase in the number of Health Sciences Center faculty with competitive R01 type grants from both public and private grantors.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Minority Biomedical Research Support - MBRS (S06)
Project #
5S06GM008244-07
Application #
3513610
Study Section
Special Emphasis Panel (SRC (01))
Project Start
1986-09-30
Project End
1995-05-14
Budget Start
1993-05-15
Budget End
1994-05-14
Support Year
7
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Howard University
Department
Type
Schools of Medicine
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Popa, Laurentiu S; Hewitt, Angela L; Ebner, Timothy J (2013) Purkinje cell simple spike discharge encodes error signals consistent with a forward internal model. Cerebellum 12:331-3
Fuller, T L; Canada, R G (1999) Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells. Cancer Chemother Pharmacol 44:249-52
Canada, R G; Paltoo, D N (1998) Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence. Biochim Biophys Acta 1448:85-98
Paltoo, D N; Canada, R G (1998) Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma. Cancer Biochem Biophys 16:213-27
Ting, P; Cushenberry, P A; Friedman, T C et al. (1997) Enhanced brain opioid receptor activity precedes blood-brain barrier disruption. Acta Neurochir Suppl 70:250-3
Mack, K M; Canada, R G; Andrews, P A (1997) The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells. Cancer Chemother Pharmacol 39:217-22
Dennis, G C; Dehkordi, O; Millis, R M et al. (1996) Monitoring of median nerve somatosensory evoked potentials during cervical spinal cord decompression. J Clin Neurophysiol 13:51-9
Canada, R G; Andrews, P A; Mack, K M et al. (1995) The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells. Biochim Biophys Acta 1267:25-30
Ting, P; Xu, S; Krumins, S (1994) Endogenous opioid system activity following temporary focal cerebral ischemia. Acta Neurochir Suppl (Wien) 60:253-6
Canada, R G (1993) Calcium receptor binding of cisplatin and terbium in human breast tumor cells after hyperthermia. Radiat Res 133:170-5